The Scientist's content tagged with: Onchocerca Volvulus. Despite a fierce civil war, scientists led a 14-year grassroots campaign that has eradicated a parasitic disease from northern Sudan.

The Food and Drug Administration (FDA) has approved moxidectin for the treatment of onchocerciasis (river blindness) due to Onchocerca volvulus in patients ≥12 years of age.. Moxidectin, a ...

Onchocerca volvulus -- the parasite that causes river blindness--has not been shown to affect brain function, which would be required if the parasite were also directly responsible for causing NS.

The federal government has reaffirmed its commitment to eliminating onchocerciasis, also known as river blindness, within the ...

In sub-Saharan Africa and parts of Latin America, there is a parasitic worm that infects about 25m people, causing serious skin diseases, epilepsy and blindness. Known as Onchocerca volvulus, it ...

The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it the fifth country globally and the first country in Africa to be ...

STROMECTOL has no activity against adult Onchocerca volvulus parasites.” The FDA adds , “some topical (on the skin) forms of ivermectin are approved to treat external parasites like head lice ...

“Onchocerciasis is caused by Onchocerca volvulus, transmitted through the bite of infected blackflies. It is the second leading cause of infectious blindness globally,” Adewale said.

Onchocerca volvulus is transmitted to humans by blackflies that live and breed near fast-flowing rivers and streams, giving the disease the “river” part of its name.

They looked at two worm species: Brugia malayi, which causes swelling of the limbs, and Onchocerca volvulus, which causes skin diseases and blindness. In both worms, ...